Reversible and Selective MAOIs in Combination with (S)SRIs: Risk of Serotonin Toxicity

MoclobemideAbstractTherapeutic doses of Moclobemide combined with any (S)SRI carries a significant risk of potentially fatal serotonin toxicity.  This is made more unpredictable because multiple pharmaco-kinetic interactions via P-450 can come…

Continue ReadingReversible and Selective MAOIs in Combination with (S)SRIs: Risk of Serotonin Toxicity